Pancreatic Cancer Action Network

First RAS Inhibitor Extends Survival in Previously Treated Metastatic Pancreatic Adenocarcinoma: What You Need to Know

Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously ...